Calonge, M.; Nieto-Miguel, T.; de la Mata, A.; Galindo, S.; Herreras, J.M.; López-Paniagua, M.
Goals and Challenges of Stem Cell-Based Therapy for Corneal Blindness Due to Limbal Deficiency. Pharmaceutics 2021, 13, 1483.
https://doi.org/10.3390/pharmaceutics13091483
AMA Style
Calonge M, Nieto-Miguel T, de la Mata A, Galindo S, Herreras JM, López-Paniagua M.
Goals and Challenges of Stem Cell-Based Therapy for Corneal Blindness Due to Limbal Deficiency. Pharmaceutics. 2021; 13(9):1483.
https://doi.org/10.3390/pharmaceutics13091483
Chicago/Turabian Style
Calonge, Margarita, Teresa Nieto-Miguel, Ana de la Mata, Sara Galindo, José M. Herreras, and Marina López-Paniagua.
2021. "Goals and Challenges of Stem Cell-Based Therapy for Corneal Blindness Due to Limbal Deficiency" Pharmaceutics 13, no. 9: 1483.
https://doi.org/10.3390/pharmaceutics13091483
APA Style
Calonge, M., Nieto-Miguel, T., de la Mata, A., Galindo, S., Herreras, J. M., & López-Paniagua, M.
(2021). Goals and Challenges of Stem Cell-Based Therapy for Corneal Blindness Due to Limbal Deficiency. Pharmaceutics, 13(9), 1483.
https://doi.org/10.3390/pharmaceutics13091483